Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Daniel Erskine

Newcastle AuthorsTitleYearFull text
Chris Hatton
Dr Amy Reeve
Dr Nichola Lax
Alex Blain
Dr Yi Ng
et al.		Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies2020
Dr Daniel Erskine
Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity2020
Dr Daniel Erskine
Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies2020
Dr Daniel Erskine
Dr Christopher Morris
Professor Johannes Attems
Investigating the Presence of Doubly‐phosphorylated α‐Synuclein at Tyrosine 125 and Serine 129 In Idiopathic Lewy Body Diseases2020
Dr Daniel Erskine
Antibodies against alpha‐synuclein: tools and therapies2019
Dr Daniel Erskine
Professor John-Paul Taylor
Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders2019
Professor Tiago Outeiro
Dr David Koss
Dr Daniel Erskine
Dr Lauren Walker
Dr Marzena Kurzawa-Akanbi
et al.		Dementia with Lewy bodies: an update and outlook2019
Dr Kirsty McAleese
Madhurima Dey
Dr Lauren Walker
Dr Daniel Erskine
Mary Johnson
et al.		Extravascular fibrinogen in the white matter of Alzheimer’s disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer’s disease2019
Dr Daniel Erskine
Dr Christopher Morris
Heterogeneity in α-synuclein sub-types and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease2019
Dr Daniel Erskine
Dr Amy Reeve
Dr Tuomo Polvikoski
Dr Andrew Schaefer
Professor Robert Taylor
et al.		Lewy body pathology is more prevalent in older individuals with mitochondrial disease than controls2019
123